D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
RGNX holding history
REGENXBIO Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RGNX overviewAll 13F holders of RGNXFull Q2 2026 holdings
- Shares (Q2 2026)
- 712,814
- Value
- $8.54M
- % of portfolio
- <0.1%
- Quarters held
- 14
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 712,814 | $8.54M | <0.1% | +426,813+149.2% | Added | Holders |
| Q1 2026 | 286,001 | $2.40M | <0.1% | +217,613+318.2% | Added | Holders |
| Q4 2025 | 68,388 | $984.8K | <0.1% | +68,388 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −63,377−100.0% | Sold out | Holders |
| Q4 2024 | 63,377 | $489.9K | <0.1% | +8,271+15.0% | Added | Holders |
| Q3 2024 | 55,106 | $578.1K | <0.1% | −87,563−61.4% | Reduced | Holders |
| Q2 2024 | 142,669 | $1.67M | <0.1% | −13,491−8.6% | Reduced | Holders |
| Q1 2024 | 156,160 | $3.29M | <0.1% | −1,480−0.9% | Reduced | Holders |
| Q4 2023 | 157,640 | $2.83M | <0.1% | +113,012+253.2% | Added | Holders |
| Q3 2023 | 44,628 | $734.6K | <0.1% | +44,628 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −12,249−100.0% | Sold out | Holders |
| Q4 2022 | 12,249 | $277.8K | <0.1% | −4,200−25.5% | Reduced | Holders |
| Q3 2022 | 16,449 | $435.0K | <0.1% | +16,449 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −60,303−100.0% | Sold out | Holders |
| Q3 2021 | 60,303 | $2.53M | <0.1% | −201,467−77.0% | Reduced | Holders |
| Q2 2021 | 261,770 | $10.2M | <0.1% | +5,545+2.2% | Added | Holders |
| Q1 2021 | 256,225 | $8.74M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.